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Abstract
Background: Diagnosis at an early stage of chronic pancreatitis (CP) is challenging. It has been reported that microRNAs
(miRNAs) are increasingly found and applied as targets for the diagnosis and treatment of various cancers. However, to
the best of our knowledge, few published papers have described the role of miRNAs in the diagnosis of CP.
Method: We downloaded gene expression profile data from the Gene Expression Omnibus and identified differentially
expressed genes (DEGs) between CP and normal samples of Harlan mice and Jackson Laboratory mice. Common DEGs
were filtered out, and the semantic similarities of gene classes were calculated using the GOSemSim software package.
The gene class with the highest functional consistency was selected, and then the Lists2Networks web-based system
was used to analyse regulatory relationships between miRNAs and gene classes. The functional enrichment of the gene
classes was assessed based on Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes pathway annotation
terms.
Results: A total of 405 common upregulated DEGs and 7 common downregulated DEGs were extracted from the two
kinds of mice. Gene cluster D was selected from the common upregulated DEGs because it had the highest semantic
similarity. miRNA 124a (miR-124a) was found to have a significant regulatory relationship with cluster D, and DEGs such
as CHSY1 and ABCC4 were found to be regulated by miR-124a. The GO term of response to DNA damage stimulus and
the pathway of Escherichia coli infection were significantly enriched in cluster D.
Conclusion: DNA damage and E. coli infection might play important roles in CP pathogenesis. In addition, miR-124a
might be a potential target for the diagnosis and treatment of CP.
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Background
Chronic pancreatitis (CP) is characterized by pancreatic
inflammation and fibrosis, and it arises when pancreatic
injury is followed by a sustained immune activation in
which fibrosis dominates [1]. Environmental triggers of
pancreatic inflammation and disease susceptibility (such
as alcohol use, smoking, pancreatic duct obstruction and
drugs) or modifying genes (including PRSS1, SPINK1
and CFTR) act synergistically to cause CP [1,2]. It has
also been indicated that CP is often an underlying cause
of pancreatic cancer [3]. Meanwhile, in recent years, re-
searchers in a growing number of studies have suggested
that microRNAs (miRNAs) play an important role in the
diagnosis and prognosis of pancreatic cancers [3-6].
miRNAs inhibit the transcription levels of mRNA, in-
duce degradation of the regulation of gene expression
[7] and have been proved to be involved in many dis-
ease processes. Therefore, the identification of miRNA
changes might explain the pathology of CP in another
way and provide a new method for diagnosing CP.
A number of miRNAs that have been studied have a
role in pancreatic diseases. By comparing pancreatic
cancer tissue to CP tissue and normal pancreas, Bloom-
ston and colleagues identified 21 miRNAs with increased
expression and 4 with decreased expression, which sug-
gests that the miRNAs likely play an important regulatory
role in pancreatic cancer [3]. It has also been demon-
strated that the expression of miRNA-196a (miR-196a) is
high in pancreatic ductal adenocarcinoma (PDAC) but
low in CP and normal tissues, whereas miR-217 exhibits* Correspondence: ajli62@gmail.com
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the opposite expression pattern [8]. The ratio of miR-196a
to miR-217 has been found to indicate whether tissue
samples contain PDAC [9]. More and more miRNAs have
been found to be related to pancreatic cancers, and CP
specimens are often used as a second control [3,9]. How-
ever, few published papers have specifically described the
relationship between CP and its miRNAs.
In the present study, we analysed the gene expression
profile of CP and normal mice to screen for differentially
expressed genes (DEGs). We identified the related miR-
NAs, which might provide further insights into the mo-
lecular mechanisms of CP. Understanding the molecular




We downloaded a gene data set [GEO:GSE41418] [10]
from the Gene Expression Omnibus (GEO) database (http://
www.ncbi.nlm.nih.gov/geo/). Gene expression analysis was
performed on a GeneChip Mouse Genome 430 Plus 2.0
Array platform (Affymetrix, Santa Clara, CA, USA). The data
set contains two different kinds of mice: Harlan mice
(C57BL/6NHsd; Harlan Laboratories, Indianapolis, IN,
USA) and Jackson Laboratory mice (C56BL/6 J; The
Jackson Laboratory, Bar Harbor, ME, USA). A frequently
used experimental model of CP recapitulating human dis-
ease is repeated injections of cerulein into mice. We found
that two common substrains of C57BL/6 mice (C56BL/6 J
and C57BL/6NHsd) exhibit different degrees of CP, with
C57BL/6 J mice being more susceptible to repetitive
cerulean-induced CP. The goal of this study was to iden-
tify genes associated with CP and to identify differentially
regulated genes between two substrains as candidates for
the CP progression. We included six mice of each type, in-
cluding three CP samples and three normal samples [10].
Identification of differentially expressed genes
Expression profile data were normalized with GeneChip
robust multiarray analysis [11]. Next, we preprocessed the
data derived from 12 samples for subsequent analysis. We
annotated expression profiling probes to gene symbols. If
there were multiple probe sets that corresponded to one
gene, the expression values of those probe sets were aver-
aged. Using this method, we obtained an expression data
set comprising 21,389 genes. Afterward, Significance Ana-
lysis of Microarrays 4.0 software [12] was used to screen
the DEGs between the CP samples and normal controls of
the two kinds of mice, respectively. The overlapping DEGs
were denoted as common DEGs and were used for further
analysis. A fold discovery rate (FDR) ≤0.05 was selected as
the threshold for screening DEGs.
Gene cluster analysis of common differentially expressed
genes
Gene cluster analysis can be used to divide genes into
several classes based on certain similarity criteria, such
as the Pearson correlation coefficient or Euclidean dis-
tance [13,14]. It has been proved that genes in the same
cluster have a high degree of homogeneity. In our
present study, we used the second-order tolerance ana-
lysis (SOTA) method [15], a toolset of gene expression
profile analysis [16], to perform cluster analysis on the
common DEGs based on the gene expression values.
The Euclidean distance was employed as the clustering
indicator. Next, we calculated the semantic similarity of
gene classes using the GOSemSim software package
[17], and the class of genes with the highest functional
consistency was selected as the optimal gene cluster for
further study.
Related microRNAs of optimal gene cluster and GO and
KEGG pathway analysis
In organisms, highly coexpressed genes are likely to share
common regulatory patterns and to participate in the
same or similar biological processes and pathways [18]. In
order to study the regulatory mechanisms of the optimal
gene cluster, we used the Lists2Networks web-based sys-
tem [19] to analyse the possible relationship between the
miRNAs and the optimal gene cluster. The functional en-
richment of the target genes of two regulators (transcrip-
tion factors and miRNAs) was assessed based on the Gene
Ontology (GO) and Kyoto Encyclopedia of Genes and
Genomes (KEGG) pathway annotation terms. GO and
KEGG signalling pathway analyses were performed using
the GOstats R package software package (http://www.r-
project.org/), with which we carried out the standard
hypergeometric test. We was also performed GO and KEGG
enrichment analysis on the gene cluster, with P-values
less than 0.05 considered statistically significant.
Results
Identification of differentially expressed genes
According to the predetermined FDR threshold ≤0.05,
962 DEGs of Harlan mice, including 911 upregulated
genes and 51 downregulated genes, were screened out.
In Jackson mice, a total of 1,545 genes were differentially
expressed, and these DEGs comprised 1,423 upregulated
genes and 122 downregulated genes. Next, we extracted
overlapping DEGs in both mice, which consisted of 405
upregulated genes and 7 downregulated genes (Figure 1).
We clearly observed that the number of upregulated
genes was significantly greater than that of downregu-
lated genes. We speculate that these upregulated genes
might play a major role in CP disease. In the experimen-
tal work following this observation, we analysed only the
upregulated common DEGs.
Yuan et al. European Journal of Medical Research 2014, 19:31 Page 2 of 6
http://www.eurjmedres.com/content/19/1/31
Gene clustering of upregulated common differentially
expressed genes
Using the Euclidean distances as the clustering indicators
in SOTA, we obtained four clearly separated gene classes
(Figure 2) of the upregulated common DEGs. Next, we
calculated the semantic similarity scores of gene classes
(Table 1). As a result, gene cluster D was found to have
the highest average semantic similarity score (0.2868) and
was selected for further analysis.
Related microRNAs and functional analysis of the optimal
gene cluster
According to the enrichment analysis of Lists2Networks,
miR-124a was found to have a significant regulation rela-
tionship with cluster D (Table 2). And genes such as CHSY
(chondroitin sulphate synthase 1) and ABCC4 (ATP-bind-
ing cassette, subfamily C (CFTR/MRP), member 4) were
enriched and in correlation with miR-124a. According to
GO and KEGG pathway enrichment on gene cluster D,
we found that the most significant biological process was
response to DNA damage stimulus (Table 3), and PAPR3
was one of the significant DEGs enriched in the GO term.
The observed significant pathways were associated with
the cell cycle and Escherichia coli infection (Table 4).
Discussion
In the present study, we screened out 405 common upreg-
ulated DEGs of the two kinds of mice used, and GOSem-
Sim was used to calculate the semantic similarity of the
gene clusters of the DEGs. Cluster D was selected as the
optimal gene class for further investigation because of it
had the highest average semantic similarity. Using the
Lists2Networks, we found that cluster D could be signifi-
cantly regulated by miR-124a, which might play an im-
portant role in the development of CP.
miR-124a was first identified by cloning studies in
mice [20]. Studies have shown that miR-124a plays an
important role in the control of cell survival, prolifera-
tion, differentiation and metabolism and whose dysfunc-
tion is a potential cause of disease [21-23]. In addition,
published data have demonstrated that miR-124a expres-
sion level was increased in the mouse pancreas at the em-
bryonic stage and have indicated its important role in
pancreas development [23]. Therefore, we hypothesized
miR-124a might play an important pathogenic role in CP.
CHSY1 encodes a member of the chondroitin N-
acetylgalactosaminyltransferase family, possesses dual glu-
curonyltransferase and galactosaminyltransferase activity
and plays critical roles in the biosynthesis of chondroitin
sulphate, a glycosaminoglycan involved in many biological
processes, including cell proliferation and morphogenesis
[24-26]. CHSY1 was one of the significant genes in cluster
D and was enriched and regulated by miR-124a. Re-
searchers in a previous study demonstrated that CHSY1
regulated its downstream target CASP1 (caspase 1, also
known as interleukin 1β–converting enzyme), which
could cleave interleukin 1β precursors into mature cyto-
kines and contribute to inflammation [27]. Surprisingly,
increased expression of CASP1 has been reported to be a
frequent event in CP [28]. Thus, miR-124a might partici-
pate in CP manifestation and development by regulating
expression levels of CHSY1 or CASP1.
ABCC4 is another significant gene regulated by miR-
124a. It is a member of the ATP-binding cassette
Figure 1 Common differentially expressed genes of the two mouse breeds studied. The red and blue parts represent, respectively, the
upregulated common differentially expressed genes (DEGs) and downregulated common DEGs.
Figure 2 Dendrogram used for clustering analysis of the common upregulated differentially expressed genes. As shown in the diagram,
the genes are divided into four categories (A, B, C and D).
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transporter superfamily, which has been shown to com-
prise key mediators of drug efflux and multidrug resist-
ance in many types of tumours and inflammatory
diseases [29-31]. A previous study also been implicated
ABCC4 as an efflux pump of proinflammatory mediators
such as LTB4 and LTC4, and ABCC4 may represent a
novel target for anti-inflammatory therapies [32]. There-
fore, miR-124a might regulate the inflammatory disease
of CP by changing the levels of proinflammatory media-
tors by ABCC4.
On the basis of the results of GO enrichment analysis
of gene cluster D, the most significant biological process
we observed was the response to DNA damage stimulus.
This suggested that DNA damage might play an import-
ant role in the pathogenesis of CP. The results of our
analysis are in line with those of a previous study [33].
PARP3 is one significant gene that is enriched in the bio-
logical process of response to DNA damage stimulus. It
belongs to the poly(ADP-ribose) polymerase (PARP)
family [34]. PARP3 catalyses the reaction of ADP ribosy-
lation, a key posttranslational modification of proteins in-
volved in different signalling pathways from DNA damage
to energy metabolism and organismal memory [35]. In
addition, recent studies have clearly demonstrated the role
of PARP activation in various forms of local inflammation
[36-38]. Information about the role of PARP3 in CP is
sparse; however, it has been shown that other members of
the PARP family, such as PARP1, coactivate the transcrip-
tion factor nuclear factor κB (NF-κB) and is required for
NF-κB-mediated inflammatory responses [39]. CP is char-
acterized by pancreatic inflammation, thus PARP3 might
potentially play a role in its inflammatory processes.
In KEGG pathway analysis, it has been shown that
E. coli infection might play an important role in CP.
Karmali and colleagues reported that infection with E. coli
produced postdiarrhoeal haemolytic uraemia syndrome
and that many patients who recovered from it had long-
term sequelae, including CP and cholelithiasis [40,41].
Furthermore, E. coli might also lead to pancreatic abscess,
which is defined as an acute inflammatory process of the
pancreas [42]. It has been proved that E. coli organisms
can induce polymorphonuclear leucocyte infiltration dur-
ing clinical infection [43]. Therefore, we suggest that
E. coli infection might be involved in the occurrence of CP.
This study has some limitations. First is the small sam-
ple size obtained from the GEO database. Second, valid-
ation of the results in other data sets or samples is
lacking. Therefore, further genetic studies with larger
sample sizes and different kinds of CP samples are
needed to confirm our observations.
Table 2 Regulatory microRNAs predicted for cluster D
Term Genes Combined score P-value
TGCCTTA, mIR-124a CHSY1, ABCC4, CASC4 8.818 0.00828
TCTAGAG, mIR-517 SLC39A10, RND3 7.065 0.03707
TAGAACC, mIR-182 FAM107B, RBM12 6.138 0.02771
Table 1 Semantic similarity scores of the gene clusters
Cluster Gene number Semantic similarity score
Cluster A 51 0.2145412
Cluster B 91 0.2525834
Cluster C 121 0.272545
Cluster D 110 0.2867982
Table 3 Gene Ontology database enrichment analysis of
cluster D
Gene Ontology term Genes P-value
Response to DNA damage stimulus PARP3, TOP2A, RAD51 0.0025
DNA metabolic process PRIM1, RFC1, PARP3 0.0041
Chromosome organisation CDCA8, H2AFX, RFC1 0.0047
Chromosome condensation NCAPH, TOP2A 0.0065
Chromosome segregation MIS12, TOP2A 0.0073
Cellular response to DNA damage
stimulus
TOPBP1, PARP3, TOP2A 0.0080
mRNA export from nucleus AGFG1, RAE1 0.0089
DNA packaging NCAPH, TOP2A 0.0106
Response to ionizing radiation TOPBP1, H2AFX 0.0115
RNA export from nucleus AGFG1, RAE1 0.0124
Endocytosis SNX4, SFTPD, CD14 0.0150
Regulation of ubiquitin-protein
ligase activity
BUB3, CDC23, CCNB1 0.0155
RNA transport AGFG1, RAE1 0.0166
DNA repair TOPBP1, PARP3, TOP2A 0.0170
Nuclear export AGFG1, RAE1 0.0290
DNA replication RFC1, TOP2A, MCM5 0.0324
Organelle organisation CDCA8, BUB3, H2AFX 0.0357
Response to stress PARP3, PHLDA3, LSP1 0.0359
Cellular response to stimulus PARP3, TOP2A, RAD51 0.0375
Innate immune response TUBB2C, SFTPD 0.0441
Table 4 KEGG enrichment analysis of cluster Da
KEGG_PATHWAY Genes P-value
hsa04110 cell cycle RBL1, CDC23, MCM5 1.80E-04
hsa05131 enteropathogenic
E. coli infection
TUBB2A, TUBB2C, CD14 0.007263
hsa05130 enteropathogenic
E. coli infection
TUBB2A, TUBB2C, CD14 0.007263
hsa04115 p53 signalling pathway CCNB1, CCNB2, APAF1 0.013926
hsa04640 hematopoietic cell lineage CD38, IL1R1, CD14 0.026877
hsa00600 sphingolipid metabolism SGMS1, B4GALT6 0.034673
aE. coli, Escherichia coli; KEGG, Kyoto Encyclopedia of Genes and Genomes.
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Conclusions
miR-124a provides some guidance for the mechanism of
CP pathogenesis and is a potential target for the diagno-
sis and treatment of CP. miR-124a might participate in
CP occurrence and development by regulating expres-
sion levels of CHSY1 or CASP1. Also, miR-124a might
regulate the inflammatory disease of CP by changing the
level of proinflammatory mediators by ABCC4. In addition,
DNA damage and E. coli infection might play important
roles in CP pathogenesis.
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